SUN PHARMACEUTICALS INDUSTRIES LTD SCREENER.

IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 Trailing Best Case Worst Case
Sales 27,392.01 28,487.03 31,578.44 26,489.46 29,065.91 32,837.50 33,498.14 38,654.49 43,885.68 48,496.85 48,496.85 54,862.78 51,562.16
Expenses 19,498.19 20,313.13 21,476.42 20,858.04 22,688.93 25,854.66 25,028.18 28,396.92 32,109.14 35,473.72 35,473.72 40,130.17 38,817.09
Operating Profit 7,893.82 8,173.90 10,102.02 5,631.42 6,376.98 6,982.84 8,469.96 10,257.57 11,776.54 13,023.13 13,023.13 14,732.61 12,745.07
Other Income 282.79 -42.50 610.40 -135.03 -258.28 382.26 -3,449.21 -3,505.16 333.32 859.87 859.87 - -
Depreciation 1,194.72 1,037.53 1,264.75 1,499.84 1,753.25 2,052.78 2,079.95 2,143.74 2,529.43 2,556.64 2,556.64 2,556.64 2,556.64
Interest 578.99 523.24 399.80 517.57 555.25 302.73 141.43 127.35 172.00 238.47 238.47 238.47 238.47
Profit before tax 6,402.90 6,570.63 9,047.87 3,478.98 3,810.20 5,009.59 2,799.37 4,481.32 9,408.43 11,087.89 11,087.89 11,937.50 9,949.96
Tax 914.69 913.77 1,211.57 911.04 600.88 822.80 514.69 1,075.50 847.59 1,439.45 1,439.45 13% 13%
Net profit 4,539.38 4,545.71 6,964.37 2,095.70 2,665.42 3,764.93 2,903.82 3,272.73 8,473.58 9,576.38 9,576.38 10,387.75 8,658.24
EPS 21.92 18.89 29.03 8.73 11.11 15.69 12.10 13.64 35.32 39.91 39.91 43.29 36.09
Price to earning 46.72 43.41 23.71 56.68 43.10 22.45 49.39 67.06 27.84 40.60 37.25 43.19 37.25
Price 1,023.90 820.00 688.15 495.10 478.85 352.30 597.80 914.75 983.10 1,620.55 1,486.70 1,869.76 1,344.16

RATIOS:
Dividend Payout 13.69% 5.29% 12.06% 22.90% 24.75% 25.49% 61.97% 73.31% 32.56% 33.82%
OPM 28.82% 28.69% 31.99% 21.26% 21.94% 21.26% 25.28% 26.54% 26.83% 26.85% 26.85%

TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST

Sales Growth 6.55% 6.32% 10.78% 13.13% 10.51% 13.13% 6.32%
OPM 26.06% 24.72% 25.59% 26.75% 26.85% 26.85% 24.72%
Price to Earning 41.66 43.05 40.77 43.19 37.25 43.19 37.25
SUN PHARMACEUTICALS INDUSTRIES LTD SCREENER.IN

Narration Dec-21 Mar-22 Jun-22 Sep-22 Dec-22 Mar-23 Jun-23 Sep-23 Dec-23 Mar-24
Sales 9,863.06 9,446.76 10,761.76 10,952.28 11,240.97 10,930.67 11,940.84 12,192.41 12,380.70 11,982.90
Expenses 7,256.73 7,106.39 7,877.37 7,995.73 8,237.25 8,128.54 8,609.07 9,013.03 8,903.87 8,947.75
Operating Profit 2,606.33 2,340.37 2,884.39 2,956.55 3,003.72 2,802.13 3,331.77 3,179.38 3,476.83 3,035.15
Other Income 432.51 -3,822.16 2.14 85.22 173.88 201.83 -118.43 293.61 180.39 504.30
Depreciation 553.68 556.47 588.00 609.95 659.95 671.53 651.32 632.82 622.14 650.36
Interest 18.97 37.34 13.69 19.39 46.18 92.74 80.88 49.29 34.73 73.57
Profit before tax 2,466.19 -2,075.60 2,284.84 2,412.43 2,471.47 2,239.69 2,481.14 2,790.88 3,000.35 2,815.52
Tax 335.39 146.76 188.99 152.26 283.43 222.91 468.10 390.10 432.32 148.93
Net profit 2,058.80 -2,277.25 2,060.88 2,262.22 2,166.01 1,984.47 2,022.54 2,375.51 2,523.75 2,654.58

OPM 26% 25% 27% 27% 27% 26% 28% 26% 28% 25%
SUN PHARMACEUTICALS INDUSTRIES LTD SCREENER.IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Equity Share Capital 207.12 240.66 239.93 239.93 239.93 239.93 239.93 239.93 239.93 239.93
Reserves 25,430.97 32,741.82 36,399.74 38,074.18 41,169.13 45,024.52 46,222.85 47,771.29 55,755.45 63,426.82
Borrowings 8,996.11 8,496.76 9,831.77 10,385.27 10,514.36 8,314.88 3,868.58 1,290.30 6,885.87 3,273.67
Other Liabilities 14,088.99 13,948.26 14,624.01 15,598.01 12,666.11 14,614.99 17,290.86 20,474.39 17,830.65 18,522.46
Total 48,723.19 55,427.50 61,095.45 64,297.39 64,589.53 68,194.32 67,622.22 69,775.91 80,711.90 85,462.88

Net Block 12,682.47 15,872.25 17,675.17 18,852.65 21,836.54 22,846.91 21,552.98 22,665.16 24,420.12 27,457.53
Capital Work in Progress 2,038.61 2,175.45 2,801.38 2,465.16 1,411.15 1,220.34 1,566.83 1,286.80 4,973.16 1,107.73
Investments 2,716.30 1,829.88 1,191.88 7,142.87 7,902.53 10,143.11 9,612.45 12,848.59 14,830.09 15,025.77
Other Assets 31,285.81 35,549.92 39,427.02 35,836.71 33,439.31 33,983.96 34,889.96 32,975.36 36,488.53 41,871.85
Total 48,723.19 55,427.50 61,095.45 64,297.39 64,589.53 68,194.32 67,622.22 69,775.91 80,711.90 85,462.88

Working Capital 17,196.82 21,601.66 24,803.01 20,238.70 20,773.20 19,368.97 17,599.10 12,500.97 18,657.88 23,349.39
Debtors 5,106.13 6,775.66 7,202.61 7,815.28 8,884.20 9,421.24 9,061.40 10,484.59 11,438.51 11,249.37
Inventory 5,667.99 6,422.54 6,832.81 6,880.69 7,885.98 7,874.99 8,997.02 8,925.13 10,513.05 9,868.29

Debtor Days 68.04 86.82 83.25 107.69 111.56 104.72 98.73 99.00 95.13 84.67
Inventory Turnover 4.83 4.44 4.62 3.85 3.69 4.17 3.72 4.33 4.17 4.91

Return on Equity 18% 14% 19% 5% 6% 8% 6% 7% 15% 15%

Return on Capital Emp 19% 21% 8% 9% 10% 6% 9% 17% 17%
SUN PHARMACEUTICALS INDUSTRIES LTD SCREENER.IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Cash from Operating Activity 5,615.74 6,685.86 7,082.21 3,907.15 2,196.45 6,554.77 6,170.37 8,984.54 4,959.33 12,134.98
Cash from Investing Activity -1,502.35 -3,949.13 -4,186.15 -3,103.80 -310.08 -2,225.32 406.53 -5,555.86 -7,219.92 -690.20
Cash from Financing Activity -1,186.53 -1,888.53 -2,285.39 -1,539.26 -2,730.52 -5,715.14 -5,980.48 -5,193.46 2,376.07 -6,710.16
Net Cash Flow 2,926.86 848.20 610.67 -735.91 -844.15 -1,385.69 596.42 -1,764.78 115.48 4,734.62
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.

After customization, you can upload this back on Screener.

Upload on: https://www.screener.in/excel/

Download your customized workbooks now onwards.

Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: [email protected]
s… do ANYTHING.
COMPANY NAME SUN PHARMACEUTICALS INDUSTRIES LTD
LATEST VERSION 2.10 PLEAS
CURRENT VERSION 2.10

META
Number of shares 239.93
Face Value 1.00
Current Price 1,486.70
Market Capitalization 356,709.13

PROFIT & LOSS

Report Date Mar-15 Mar-16 Mar-17 Mar-18
Sales 27,392.01 28,487.03 31,578.44 26,489.46
Raw Material Cost 6,624.68 6,724.15 8,402.37 7,193.98
Change in Inventory -114.49 393.77 271.63 -230.70
Power and Fuel 560.77 545.44 525.09 559.97
Other Mfr. Exp 1,427.56 1,808.55 1,973.46 1,828.35
Employee Cost 4,502.64 4,772.31 4,902.30 5,367.05
Selling and admin 5,131.37 5,219.20 5,224.61 4,727.00
Other Expenses 1,136.68 1,637.25 720.22 950.99
Other Income 282.79 -42.50 610.40 -135.03
Depreciation 1,194.72 1,037.53 1,264.75 1,499.84
Interest 578.99 523.24 399.80 517.57
Profit before tax 6,402.90 6,570.63 9,047.87 3,478.98
Tax 914.69 913.77 1,211.57 911.04
Net profit 4,539.38 4,545.71 6,964.37 2,095.70
Dividend Amount 621.36 240.66 839.76 479.86

Quarters
Report Date Dec-21 Mar-22 Jun-22 Sep-22
Sales 9,863.06 9,446.76 10,761.76 10,952.28
Expenses 7,256.73 7,106.39 7,877.37 7,995.73
Other Income 432.51 -3,822.16 2.14 85.22
Depreciation 553.68 556.47 588.00 609.95
Interest 18.97 37.34 13.69 19.39
Profit before tax 2,466.19 -2,075.60 2,284.84 2,412.43
Tax 335.39 146.76 188.99 152.26
Net profit 2,058.80 -2,277.25 2,060.88 2,262.22
Operating Profit 2,606.33 2,340.37 2,884.39 2,956.55

BALANCE SHEET
Report Date Mar-15 Mar-16 Mar-17 Mar-18
Equity Share Capital 207.12 240.66 239.93 239.93
Reserves 25,430.97 32,741.82 36,399.74 38,074.18
Borrowings 8,996.11 8,496.76 9,831.77 10,385.27
Other Liabilities 14,088.99 13,948.26 14,624.01 15,598.01
Total 48,723.19 55,427.50 61,095.45 64,297.39
Net Block 12,682.47 15,872.25 17,675.17 18,852.65
Capital Work in Progress 2,038.61 2,175.45 2,801.38 2,465.16
Investments 2,716.30 1,829.88 1,191.88 7,142.87
Other Assets 31,285.81 35,549.92 39,427.02 35,836.71
Total 48,723.19 55,427.50 61,095.45 64,297.39
Receivables 5,106.13 6,775.66 7,202.61 7,815.28
Inventory 5,667.99 6,422.54 6,832.81 6,880.69
Cash & Bank 10,998.04 13,181.65 15,140.84 9,929.38
No. of Equity Shares ### ### ### ###
New Bonus Shares
Face value 1.00 1.00 1.00 1.00

CASH FLOW:
Report Date Mar-15 Mar-16 Mar-17 Mar-18
Cash from Operating Activity 5,615.74 6,685.86 7,082.21 3,907.15
Cash from Investing Activity -1,502.35 -3,949.13 -4,186.15 -3,103.80
Cash from Financing Activity -1,186.53 -1,888.53 -2,285.39 -1,539.26
Net Cash Flow 2,926.86 848.20 610.67 -735.91

PRICE: 1,023.90 820.00 688.15 495.10

DERIVED:
Adjusted Equity Shares in Cr 207.12 240.67 239.93 239.93
 PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

29,065.91 32,837.50 33,498.14 38,654.49 43,885.68 48,496.85
8,302.08 8,929.60 9,328.30 10,459.15 11,349.07 10,370.48
433.11 -300.85 638.22 107.61 686.91 -292.13
613.60 621.89 627.09 702.78 830.05
1,884.71 1,690.00 1,723.78 1,880.71 1,936.77
5,967.09 6,362.35 6,862.23 7,300.83 8,296.03 9,429.06
5,350.33 6,995.37 6,283.41 7,366.88 9,482.36
1,004.23 954.60 841.59 794.18 901.77 15,382.05
-258.28 382.26 -3,449.21 -3,505.16 333.32 859.87
1,753.25 2,052.78 2,079.95 2,143.74 2,529.43 2,556.64
555.25 302.73 141.43 127.35 172.00 238.47
3,810.20 5,009.59 2,799.37 4,481.32 9,408.43 11,087.89
600.88 822.80 514.69 1,075.50 847.59 1,439.45
2,665.42 3,764.93 2,903.82 3,272.73 8,473.58 9,576.38
659.81 959.72 1,799.48 2,399.30 2,759.20 3,239.06

Dec-22 Mar-23 Jun-23 Sep-23 Dec-23 Mar-24

11,240.97 10,930.67 11,940.84 12,192.41 12,380.70 11,982.90
8,237.25 8,128.54 8,609.07 9,013.03 8,903.87 8,947.75
173.88 201.83 -118.43 293.61 180.39 504.30
659.95 671.53 651.32 632.82 622.14 650.36
46.18 92.74 80.88 49.29 34.73 73.57
2,471.47 2,239.69 2,481.14 2,790.88 3,000.35 2,815.52
283.43 222.91 468.10 390.10 432.32 148.93
 2,166.01 1,984.47 2,022.54 2,375.51 2,523.75 2,654.58
3,003.72 2,802.13 3,331.77 3,179.38 3,476.83 3,035.15

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

239.93 239.93 239.93 239.93 239.93 239.93
41,169.13 45,024.52 46,222.85 47,771.29 55,755.45 63,426.82
10,514.36 8,314.88 3,868.58 1,290.30 6,885.87 3,273.67
12,666.11 14,614.99 17,290.86 20,474.39 17,830.65 18,522.46
64,589.53 68,194.32 67,622.22 69,775.91 80,711.90 85,462.88
21,836.54 22,846.91 21,552.98 22,665.16 24,420.12 27,457.53
1,411.15 1,220.34 1,566.83 1,286.80 4,973.16 1,107.73
7,902.53 10,143.11 9,612.45 12,848.59 14,830.09 15,025.77
33,439.31 33,983.96 34,889.96 32,975.36 36,488.53 41,871.85
64,589.53 68,194.32 67,622.22 69,775.91 80,711.90 85,462.88
8,884.20 9,421.24 9,061.40 10,484.59 11,438.51 11,249.37
7,885.98 7,874.99 8,997.02 8,925.13 10,513.05 9,868.29
7,275.60 6,487.55 6,445.51 5,033.35 5,770.29 10,520.68
### ### ### ### ###

1.00 1.00 1.00 1.00 1.00 1.00

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

2,196.45 6,554.77 6,170.37 8,984.54 4,959.33 12,134.98
-310.08 -2,225.32 406.53 -5,555.86 -7,219.92 -690.20
-2,730.52 -5,715.14 -5,980.48 -5,193.46 2,376.07 -6,710.16
-844.15 -1,385.69 596.42 -1,764.78 115.48 4,734.62

478.85 352.30 597.80 914.75 983.10 1,620.55

239.93 239.93 239.93 239.93 239.93 239.93